A Gram-positive obligate anaerobe in the family Ruminococcaceae (Clostridium cluster IV) whose defining metabolic activity is the degradation of dietary flavonoids — the very polyphenols that serve as anti-inflammatory, antioxidant, and antimicrobial agents. When Flavonifractor is enriched, it effectively neutralizes one of the body's key dietary defenses before those compounds can act.
Flavonoid Degradation
- Flavonifractor plautii (formerly Clostridium orbiscindens) cleaves the C-ring of flavonoids including quercetin, kaempferol, naringenin, and catechins, converting them to inactive phenolic acids.
- This degradation occurs in the colon before flavonoids can exert their local anti-inflammatory effects on the gut epithelium or be absorbed systemically.
- The clinical implication is direct: *patients with high Flavonifractor abundance may derive less benefit from flavonoid-rich diets or polyphenol supplementation*, because the compounds are destroyed before they can act.
Disease Associations
Fibromyalgia
- Minerbi et al. (2019) identified Flavonifractor among taxa significantly enriched in fibromyalgia patients compared to healthy controls, with abundance correlating with symptom severity.
- Goudman et al. (2024) meta-analysis confirmed Flavonifractor enrichment as a reproducible finding across fibromyalgia cohorts.
- Mechanism hypothesis: Flavonifractor removes dietary anti-inflammatory polyphenols, contributing to the systemic low-grade inflammation characteristic of fibromyalgia.
Chronic Kidney Disease (CKD)
- Wang et al. (2023) and Zhang et al. (2023) reported Flavonifractor enrichment in CKD patients, with increasing abundance across disease stages.
- In CKD, flavonoid degradation may remove renoprotective polyphenols while generating phenolic metabolites that contribute to uremic toxin burden.
Clinical Significance
- Flavonifractor represents a mechanism by which dysbiosis can neutralize dietary interventions — a patient consuming an anti-inflammatory diet rich in polyphenols may see limited benefit if Flavonifractor is degrading those compounds.
- This has implications for precision nutrition: microbiome composition may need to be assessed before recommending polyphenol-based interventions.
- Strategies to reduce Flavonifractor abundance (or protect flavonoids from degradation) could enhance the efficacy of dietary and supplemental polyphenols.
Cross-References
- butyrate — SCFA production ecosystem that Flavonifractor disrupts indirectly
- fibromyalgia — Primary disease association
- chronic kidney disease — Secondary disease association
- biomarkers — Flavonifractor as potential marker for polyphenol non-response